Efficient circadian and related system modulation with a sleep mask

US9707409B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9707409-B2
Application numberUS-201113696858-A
CountryUS
Kind codeB2
Filing dateApr 25, 2011
Priority dateMay 14, 2010
Publication dateJul 18, 2017
Grant dateJul 18, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Light therapy is provided to a subject through a sleep mask. The sleep mask is configured to deliver electromagnetic radiation to the closed eyelids of the subject within a defined optimal wavelength band that is therapeutically impactful in modulating circadian and related systems of the subject.

First claim

Opening claim text (preview).

The invention claimed is: 1. A sleep mask configured to provide light therapy to a subject, the sleep mask comprising: a shield configured to cover the eyes of a subject wearing the sleep mask such that the shield provides a barrier between ambient radiation and the eyes of the subject; a radiation source carried by the shield, the radiation source being configured to emit radiation onto a closed eyelid of the subject if the subject is wearing the sleep mask, wherein the radiation emitted by the radiation source is within a wavelength band between 490 nm and 520 nm; and a controller configured to: control emission of radiation by the radiation source to facilitate estimation of eyelid attenuation for the closed eyelid of the subject by the controller; estimate eyelid attenuation for the closed eyelid of the subject; and control emission of radiation by the radiation source based on the estimation of eyelid attenuation for the closed eyelid of the subject according to a light therapy plan that specifies an irradiance within the wavelength band that impacts a sleep cycle of the subject such that the radiation emitted by the radiation source within the wavelength band will have the irradiance specified by the light therapy plan after the radiation has been attenuated by the eyelid of the subject. 2. The sleep mask of claim 1 , wherein the light therapy plan dictates continuous emission of the radiation by the radiation source at a fixed intensity. 3. The sleep mask of claim 1 , wherein the light therapy plan dictates emission of the radiation by the radiation source in pulses. 4. The sleep mask of claim 1 , wherein the wavelength band is between 500 nm and 510 nm. 5. A method of providing light therapy to a subject, the method comprising: emitting electromagnetic radiation onto a closed eyelid of the subject, wherein the emitted radiation is within a wavelength band between 490 nm and 520 nm; controlling emission of the electromagnetic radiation to facilitate estimation of eyelid attenuation for the closed eyelid of the subject; estimating eyelid attenuation for the closed eyelid of the subject; and controlling emission of the electromagnetic radiation based on the estimation of eyelid attenuation for the closed eyelid of the subject according to a light therapy plan that specifies an irradiance within the wavelength band that impacts a sleep cycle of the subject such that the emitted radiation within the wavelength band will have the irradiance specified by the light therapy plan after the radiation has been attenuated by the eyelid of the subject. 6. The method of claim 5 , wherein the light therapy plan dictates continuous emission of the radiation at a fixed intensity. 7. The method of claim 5 , wherein the light therapy plan dictates emission of the radiation in pulses. 8. The method of claim 5 , wherein the wavelength band is between 500 nm and 510 nm. 9. A system configured to provide light therapy to a subject, the system comprising: means for emitting electromagnetic radiation onto a closed eyelid of the subject, wherein the emitted radiation is within a wavelength band between 490 nm and 520 nm; means for controlling emission of the electromagnetic radiation to facilitate estimation of eyelid attenuation for the closed eyelid of the subject; means for estimating eyelid attenuation for the closed eyelid of the subject; and means for controlling emission of the electromagnetic radiation based on the estimation of eyelid attenuation for the closed eyelid of the subject according to a light therapy plan that specifies an irradiance within the wavelength band that impacts a sleep cycle of the subject such that the emitted radiation within the wavelength band will have the irradiance specified by the light therapy plan after the radiation has been attenuated by the eyelid of the subject. 10. The system of claim 9 , wherein the light therapy plan dictates continuous emission of the radiation by the means for emitting electromagnetic radiation at a fixed intensity. 11. The system of claim 9 , wherein the light therapy plan dictates emission of the radiation by the means for emitting electromagnetic radiation in pulses. 12. The system of claim 9 , wherein the wavelength band is between 500 nm and 510 nm.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9707409B2 cover?
Light therapy is provided to a subject through a sleep mask. The sleep mask is configured to deliver electromagnetic radiation to the closed eyelids of the subject within a defined optimal wavelength band that is therapeutically impactful in modulating circadian and related systems of the subject.
Who is the assignee on this patent?
Colbaugh Michael Edward, Koninklijke Philips Nv
What technology area does this patent fall under?
Primary CPC classification A61N5/0618. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).